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CI = 40.7–59.5 million), resulted in a statin prescription repre-
senting 24%, and 22%, of the total visits for the two conditions
respectively. Patients aged 41–60 years (OR = 3.49, 95%
CI = 1.43–8.47) or 61–80 years (OR = 3.98, 95% CI = 1.40–
11.31), or those from metropolitan areas (OR: 2.23, 95% CI:
1.11–4.48) were more likely to receive a statin prescription
compared to the respective baseline groups. Whereas residing in
the northeast (OR = 0.44, 95% CI = 0.26–0.75) or midwest
(OR = 0.40, 95% CI = 0.21–0.77) regions or being black
(OR = 0.50, 95% CI = 0.29–0.87) predict signiﬁcantly lower
odds of receiving statin prescription compared with the south
region and nonhispanic whites or other race groups. CONCLU-
SION: As expected, age was the most important factor determin-
ing the prescribing of statins in hypertension and/or diabetes. It is
not clear if these rates of statin prescribing reﬂect aggressive
off-label prescribing or undercoding of on-label diagnoses. Data
on more years needs to be analyzed to conﬁrm the ﬁndings.
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OBJECTIVE: To investigate the trend of ambulatory calcium
channel blockers (CCBs) utilization in Taiwan according to the
national health insurance claims over an eight-year period.
Special attention would be paid to the extent and situations of
prescribing ﬁrst-line (short-acting) CCBs on a PRN (pro re nata)
order. METHODS: The visit-based sampling claims datasets
of ambulatory care visits from 1997 to 2004, offered by the
National Health Insurance Research Database, were analyzed.
The datasets represented 0.2% of total ambulatory care visits
within the National Health Insurance in Taiwan. The utilization
of CCBs was stratiﬁed by ingredient and formulation, and the
prescriptions of CCBs on a PRN order by the patient’s age, the
prescribing physician’s specialty, and the setting of health care
facility. RESULTS: During the study period, the CCBs had
remained as the most popular antihypertensive agents in Taiwan.
The number of deﬁned daily doses (DDDs) of all CCBs per 1000
inhabitants per day increased from 15.3 in 1997 to 36.4 in 2004.
The growth of CCBs was attributed to second- and third-
generation CCBs, especially amlodipine. While the ﬁrst-line
CCBs, mainly short-acting nifedipine, became less popular with
time (from 6.0 DDDs per 1000 inhabitants per day in 1997 to
3.5 in 2004), their PRN use did not have a diminishing trend. In
2004, the short-acting nifedipine on a PRN order still existed in
1.5% of prescriptions containing antihypertensive agents and
3.4% of prescriptions containing CCBs. More than one half of
these PRN orders were prescribed by the internists and to the
elderly patients; almost four-ﬁfths of these PRN orders were
prescribed during normal consultations. CONCLUSION: The
physicians in Taiwan still had the habit of prescribing short-
acting CCBs both on regular use and on PRN use. The reason
for such practices and the impact on patients’ health deserve
attention.
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OBJECTIVE: This study examined associations between pre and
post stroke statin use with health care costs among elderly stroke
survivors enrolled in a Medicare Health Maintenance Organiza-
tion (HMO). METHODS: This was a retrospective analysis of
Medicare HMO in the southeastern region of United States.
Stroke survivors were identiﬁed using primary inpatient dis-
charge codes of 434.xx or 436.xx during the ‘enrollment period’
from January 1, 2000 to December 31, 2002. Patients were
required to have at least 2 prescription ﬁlls for HMG-CoA reduc-
tase inhibitors (statin) and continuous eligibility to the HMO
beneﬁts during index period. Medication adherence was calcu-
lated using prescription reﬁlls. Multivariate log-linear regression
analyses were used to determine predictors of health care costs.
RESULTS: A total 181 stroke patients with mean age of 74.3
years (SD = 7.6) and over 60% were studied. Over 55.2%
patients were on atorvastatin, followed by simvastatin with
24.3%. The average medication possession ratio for statins
was 49.6%. Patients reported poor health status and signiﬁcant
comorbidity. In multivariate log-linear regression analyses
factors, we found that statin use in the year prior to stroke (27%
of the patients) was signiﬁcantly associated with decreased health
care costs (p < 0.05). The only other factor signiﬁcantly associ-
ated with increased health care costs in the post-stroke year
was increased comorbidity severity (p < 0.001). CONCLUSION:
Statin use in elderly HMO enrolled elderly patients in the pre-
stroke period was signiﬁcantly associated with signiﬁcant reduc-
tions in health care utilization and costs in the post-stroke year.
Prophylactic statin use in elderly patients at risk for stroke may
be warranted to decrease post-stroke morbidity resulting in sig-
niﬁcant health care costs.
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OBJECTIVE: To estimate and compare annual medical expen-
ditures and utilization attributed to hypertension in men and
women of the U.S. And to investigate predisposing, enabling and
need predictors of gender differences in hypertension attribut-
able medical expenditures and utilization. METHODS: Proce-
dural equity was assessed by applying the theoretical framework
developed by Aday et.al. We used the 2001–2004 Medical
Expenditure Panel Survey (MEPS) and regression models to esti-
mate medical expenditures and utilization. A cross-sectional
study design was used and unit of analysis was person-year. The
interaction between hypertension and gender was used to study
gender differences. We estimated incremental health care utiliza-
tions attributed to hypertension as difference in utilization and
expenditures between hypertensive and non-hypertensive indi-
viduals. Percentage changes in total and attributable utilization
and expenditures of hypertensive men relative to hypertensive
women were also estimated. RESULTS: Weighted mean total
medical expenditure for hypertensive women and men was
$5512 and $5266 respectively. However, total expenditure
attributable to hypertension for hypertensive women and men
was $3272 and $3910 respectively. Therefore, hypertensive men
had 19.5% more attributable expenditures relative to hyperten-
sive women. Hypertensive women had signiﬁcantly more ofﬁce
visits, prescription drug and outpatient visits. However, similar
to total expenditure, hypertensive men had 27.3% more ofﬁce
visits, 2.9% more prescription drug, and 10.9% more outpatient
visits that is attributable to hypertension than hypertensive
women. CONCLUSION: Gender remained signiﬁcant predictor
of resource use even after controlling for predisposing, enabling
and need factors. Hypertensive women had more utilization and
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